Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.
暂无分享,去创建一个
D. Heron | R. Lalonde | R. Selvaraj | S. Beriwal | J. Kelley | R. Edwards | Hayeon Kim | G. Gan | R. Edwards
[1] D. Heron,et al. Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy. , 2006, Gynecologic oncology.
[2] D. Heron,et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. , 2006, Gynecologic oncology.
[3] Joseph K Salama,et al. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. , 2006, International journal of radiation oncology, biology, physics.
[4] D. Heron,et al. The Potential Nephrotoxic Effects of Intensity Modulated Radiotherapy Delivered to the Para-Aortic Area of Women With Gynecologic Malignancies: Preliminary Results , 2006, American journal of clinical oncology.
[5] Dwight E Heron,et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. , 2005, International journal of radiation oncology, biology, physics.
[6] John C Roeske,et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. , 2005, International journal of radiation oncology, biology, physics.
[7] Jun Duan,et al. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. , 2004, International journal of radiation oncology, biology, physics.
[8] P. Grigsby,et al. Lymph node control in cervical cancer. , 2004, International journal of radiation oncology, biology, physics.
[9] Sasa Mutic,et al. Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. , 2004, International journal of radiation oncology, biology, physics.
[10] Mitchell Morris,et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] John C Roeske,et al. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. , 2003, International journal of radiation oncology, biology, physics.
[12] B. Vikram,et al. Extended‐field radiotherapy and high–dose‐rate brachytherapy in carcinoma of the uterine cervix , 2003, Cancer.
[13] B. Vikram,et al. Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer , 2002, International Journal of Gynecologic Cancer.
[14] John C Roeske,et al. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[15] F Dehdashti,et al. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Roeske,et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. , 2001, Gynecologic oncology.
[17] P. Grigsby,et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] B N Bundy,et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] B N Bundy,et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.
[20] B N Bundy,et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. , 1999, The New England journal of medicine.
[21] H. Averette,et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. , 1998, International journal of radiation oncology, biology, physics.
[22] H. Averette,et al. 5-year survival of patients with periaortic nodal metastases in clinical stage IB and IIA cervical carcinoma. , 1989, Gynecologic oncology.
[23] B. Hilaris,et al. The role of paraaortic node irradiation in the treatment of cancer of the cervix. , 1985, International journal of radiation oncology, biology, physics.
[24] P. Disaia,et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). , 1984, Gynecologic oncology.
[25] M. Piver,et al. Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. , 1981, American journal of obstetrics and gynecology.
[26] E. W. Bradley,et al. Antherosclerosis and neoplasia in photon and neutron irradiated canines , 1980 .
[27] J. Mikuta,et al. Treatment of para‐aortic nodes in carcinoma of the cervix , 1975, Cancer.
[28] P. Grigsby,et al. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. , 2001, International journal of radiation oncology, biology, physics.
[29] P. Grigsby,et al. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10. , 1998, International journal of radiation oncology, biology, physics.
[30] T. Pajak,et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. , 1995, JAMA.